Learn more →
Back to Expert Scholars
clinical / clinicalsarcoma oncology

Jean-Yves Blay

让-伊夫·布莱

MD, PhD

🏢Centre Léon Bérard / Université Claude Bernard Lyon 1(里昂贝拉尔中心 / 里昂第一大学)🌐France

Professor of Medical Oncology; Director, Centre Léon Bérard肿瘤内科学教授;贝拉尔中心主任

55
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Jean-Yves Blay is a leading European sarcoma oncologist and director of the Centre Léon Bérard in Lyon, one of Europe's premier comprehensive cancer centers. He has driven landmark EORTC sarcoma trials and spearheaded the creation of the European Sarcoma Network Working Group (ESMO/EORTC). His research encompasses molecular classification of sarcomas, CDK4 amplification in well-differentiated liposarcoma, and immunotherapy approaches in sarcoma subtypes.

Share:

🧪Research Fields 研究领域

Soft Tissue Sarcoma软组织肉瘤
GIST胃肠道间质瘤
Liposarcoma脂肪肉瘤
CDK4 InhibitorsCDK4抑制剂
European Sarcoma Guidelines欧洲肉瘤指南

🎓Key Contributions 主要贡献

European Sarcoma Network and NETSARC

Founded and leads NETSARC, the French national network for sarcoma diagnosis and treatment, and helped build the pan-European contiCANet network, dramatically improving expert pathology review rates and clinical outcomes for sarcoma patients across Europe.

CDK4 Amplification in Liposarcoma

Contributed seminal work characterizing CDK4 gene amplification and MDM2 co-amplification as hallmarks of well-differentiated and dedifferentiated liposarcoma, enabling molecular diagnostic criteria and informing CDK4 inhibitor clinical trials.

Trabectedin and Novel Sarcoma Therapies

Led key European clinical trials of trabectedin (Yondelis) in translocation-related sarcomas, demonstrating particular activity in myxoid liposarcoma and establishing a molecular subtype-driven approach to sarcoma therapy.

Representative Works 代表性著作

[1]

Trabectedin in Unresectable or Metastatic Uterine Leiomyosarcomas and Soft Tissue Sarcomas: Updated Results from a Randomised, Open-Label, Multicentre, Phase 2 Study

The Lancet Oncology (2017)

Phase 2 trial supporting trabectedin activity in translocation-related sarcomas.

[2]

Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines

Annals of Oncology (2021)

Comprehensive ESMO guidelines for soft tissue sarcoma diagnosis and treatment, co-authored as chair.

🏆Awards & Recognition 奖项与荣誉

🏆ESMO Award for Excellence in Oncology Education 2018
🏆Chevalier de l'Ordre National du Mérite 2016
🏆CTOS Distinguished Service Award 2020

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 让-伊夫·布莱 的研究动态

Follow Jean-Yves Blay's research updates

留下邮箱,当我们发布与 Jean-Yves Blay(Centre Léon Bérard / Université Claude Bernard Lyon 1)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment